Cargando…
Immunohistochemical correlates of TP53 somatic mutations in cancer
Despite controversy on the correlation between p53 accumulation and TP53 mutational status, ihas long been used as a surrogate method for mutation analysis. The aim of our study was to characterise the IHC expression features of TP53 somatic mutations and define their occurrence in human cancers. A...
Autores principales: | Murnyák, Balázs, Hortobágyi, Tibor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323125/ https://www.ncbi.nlm.nih.gov/pubmed/27626311 http://dx.doi.org/10.18632/oncotarget.11912 |
Ejemplares similares
-
Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma
por: Murnyak, Balazs, et al.
Publicado: (2021) -
TP53 Mutation in Correlation to Immunohistochemical Expression of P53 Protein in Patients with Hepatocellular Carcinoma
por: Nikolova, Dafina, et al.
Publicado: (2018) -
PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma
por: Murnyák, Balázs, et al.
Publicado: (2017) -
Immunological Role of TP53 Somatic Mutation Classification in Human Cancers
por: Fang, Jianfei, et al.
Publicado: (2023) -
Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers
por: Zhang, Wensheng, et al.
Publicado: (2017)